secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2022-05-06T23:59:59+00:00
Accession:  0001493152-22-012395
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity director Stephen Salmon resigns; Ronald McClurg appointed to board
-----------------------------------------------------------------------------

- Stephen Salmon resigned from board and compensation committee effective May 2, 2022; no disagreement cited.
- Ronald McClurg appointed on May 4, 2022 to fill vacancy; will receive standard non-employee director compensation.
- McClurg was VP Finance & Administration/CFO of Incisive Surgical from 2003-2019; consultant since 2020.
- No material transaction interests or committee assignments disclosed for McClurg.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315222012395/0001493152-22-012395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315222012395/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-012395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer